Showing 1 - 20 results of 690 for search '(((( cloud ((a decrease) OR (_ decrease)) ) OR ( _ largest decrease ))) OR ( m6a site decrease ))', query time: 0.46s Refine Results
  1. 1

    HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters by Arash GhorbanniaDelavar (22563696)

    Published 2025
    “…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …”
  2. 2

    Thematic clouds for lectures. by Ignacio García-Espona (21395335)

    Published 2025
    “…The USA featured the largest number of lecturers (69.44%), while the presentations of posters were more balanced among the 4 countries that exhibited the highest levels of production (i.e., Brazil, the USA, Mexico and South Korea). …”
  3. 3

    Thematic cloud for posters [2013-23]. by Ignacio García-Espona (21395335)

    Published 2025
    “…The USA featured the largest number of lecturers (69.44%), while the presentations of posters were more balanced among the 4 countries that exhibited the highest levels of production (i.e., Brazil, the USA, Mexico and South Korea). …”
  4. 4
  5. 5
  6. 6

    Table 1_Demethylase FTO mediates m6A modification of ENST00000619282 to promote apoptosis escape in rheumatoid arthritis and the intervention effect of Xinfeng Capsule.docx by Fanfan Wang (1669474)

    Published 2025
    “…Bioinformatics prediction, MeRIP-qPCR, RIP, and RNA pull-down assays were employed to identify the m6A modification sites of ENST00000619282 and their interactions with FTO/YTHDF1. …”
  7. 7

    The m6A reader YTHDF2 protects vascular smooth muscle cells against the osteogenic differentiation through targeting Runx2 by Lanmei Li (21338609)

    Published 2025
    “…These results suggest that YTHDF2 directly binds to the m6A modification site of Runx2 to mediate the mRNA degradation that prevents VC by inhibiting the osteogenic development of VSMCs. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20